Microneedle/nanoencapsulation-mediated transdermal delivery: Mechanistic insights

Graphical abstract Using PLGA nanoparticles (NPs) with similar size and zeta potential, skin permeation of nanocapsulated dyes across microneedle-treated skin is determined by the molecular characteristics. Findings are important for the microneedle-mediated transdermal and dermal delivery of nanocapsulated therapeutic agents.

[1]  Claus-Michael Lehr,et al.  Nanoparticles--an efficient carrier for drug delivery into the hair follicles. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[2]  Marc Schneider,et al.  Depth profiling of gold nanoparticles and characterization of point spread functions in reconstructed and human skin using multiphoton microscopy , 2012, Journal of biophotonics.

[3]  Yuqin Qiu,et al.  Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Hervé Bourhy,et al.  Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults. , 2010, Vaccine.

[5]  B. Evrard,et al.  Skin penetration behaviour of liposomes as a function of their composition. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[6]  Chong-K. Kim,et al.  Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes. , 2006, Biomaterials.

[7]  Eric W. Smith,et al.  Penetration enhancement of transdermal delivery--current permutations and limitations. , 2004, Critical reviews in therapeutic drug carrier systems.

[8]  R. Weissleder,et al.  One-Pot Synthesis of New Symmetric and Asymmetric Xanthene Dyes. , 2007, Tetrahedron letters.

[9]  R H Guy,et al.  Skin penetration and distribution of polymeric nanoparticles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Ryan F Donnelly,et al.  Effects of microneedle length, density, insertion time and multiple applications on human skin barrier function: assessments by transepidermal water loss. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[11]  W. Sterry,et al.  Innovative liposomes as a transfollicular drug delivery system: penetration into porcine hair follicles. , 2006, The Journal of investigative dermatology.

[12]  Jing Gao,et al.  Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles. , 2010, International journal of pharmaceutics.

[13]  Heike Bunjes,et al.  Interaction of lipid nanoparticles with human epidermis and an organotypic cell culture model. , 2008, International journal of pharmaceutics.

[14]  Thiago Caon,et al.  Evaluation of the transdermal permeation of different paraben combinations through a pig ear skin model. , 2010, International journal of pharmaceutics.

[15]  Michał R. Radowski,et al.  Influence of nanocarrier type and size on skin delivery of hydrophilic agents. , 2009, International journal of pharmaceutics.

[16]  A. Stinchcomb,et al.  Vehicle Composition Influence on the Microneedle-Enhanced Transdermal Flux of Naltrexone Hydrochloride , 2010, Pharmaceutical Research.

[17]  V. Meidan,et al.  Effect of microneedle treatment on the skin permeation of a nanoencapsulated dye , 2012, The Journal of pharmacy and pharmacology.

[18]  R. Langer,et al.  Enhancing the transdermal delivery of rigid nanoparticles using the simultaneous application of ultrasound and sodium lauryl sulfate. , 2011, Biomaterials.

[19]  P. Crooks,et al.  Flux Across of Microneedle-treated Skin is Increased by Increasing Charge of Naltrexone and Naltrexol In Vitro , 2008, Pharmaceutical Research.

[20]  M. R. Kumar,et al.  PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug. , 2008, Journal of pharmaceutical sciences.

[21]  Keizo Fukushima,et al.  Two-layered dissolving microneedles formulated with intermediate-acting insulin. , 2012, International journal of pharmaceutics.

[22]  Peter McLoughlin,et al.  Microneedle mediated delivery of nanoparticles into human skin. , 2009, International journal of pharmaceutics.

[23]  Sion A. Coulman,et al.  Minimally invasive cutaneous delivery of macromolecules and plasmid DNA via microneedles. , 2006, Current drug delivery.

[24]  H. Terada,et al.  Enhanced transdermal permeability of estradiol using combination of PLGA nanoparticles system and iontophoresis. , 2012, Colloids and surfaces. B, Biointerfaces.

[25]  Xueying Ding,et al.  Combination of Microneedles with PLGA Nanoparticles as a Potential Strategy for Topical Drug Delivery , 2011 .

[26]  Stefan W. Hell,et al.  Aberrations in confocal and multi-photon fluorescence microscopy induced by refractive index mismatch , 2006 .

[27]  M. Kietzmann,et al.  Microneedle pretreatment enhances the percutaneous permeation of hydrophilic compounds with high melting points , 2012, BMC Pharmacology and Toxicology.

[28]  M. Lepage,et al.  Diffusion of rhodamine B and bovine serum albumin in fibrin gels seeded with primary endothelial cells. , 2012, Colloids and surfaces. B, Biointerfaces.

[29]  Mark G. Allen,et al.  Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  L. Aurelian,et al.  ΔRR vaccination protects from KA-induced seizures and neuronal loss through ICP10PK-mediated modulation of the neuronal-microglial axis , 2008, Genetic vaccines and therapy.

[31]  William W. Yu,et al.  Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes. , 2008, Toxicology and applied pharmacology.

[32]  Mike Heilemann,et al.  Fluorescence microscopy beyond the diffraction limit. , 2010, Journal of biotechnology.

[33]  Desmond I. J. Morrow,et al.  Microneedle-mediated intradermal nanoparticle delivery: Potential for enhanced local administration of hydrophobic pre-formed photosensitisers. , 2010, Photodiagnosis and photodynamic therapy.

[34]  Ryan F. Donnelly,et al.  Design, Optimization and Characterisation of Polymeric Microneedle Arrays Prepared by a Novel Laser-Based Micromoulding Technique , 2010, Pharmaceutical Research.

[35]  Kosmas Kretsos,et al.  Partitioning, diffusivity and clearance of skin permeants in mammalian dermis. , 2008, International journal of pharmaceutics.

[36]  Jung-Hwan Park,et al.  Microneedles for drug and vaccine delivery. , 2012, Advanced drug delivery reviews.

[37]  Clive G. Wilson,et al.  Flux of ionic dyes across microneedle-treated skin: effect of molecular characteristics. , 2012, International journal of pharmaceutics.

[38]  M. Brinkley.  A brief survey of methods for preparing protein conjugates with dyes, haptens, and cross-linking reagents. , 1992, Bioconjugate chemistry.

[39]  A. Stinchcomb,et al.  Naltrexone salt selection for enhanced transdermal permeation through microneedle-treated skin. , 2012, Journal of pharmaceutical sciences.

[40]  Clive G. Wilson,et al.  Laser-engineered dissolving microneedles for active transdermal delivery of nadroparin calcium. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[41]  Hirenkumar K. Makadia,et al.  Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier. , 2011, Polymers.

[42]  Corona M. Cassidy,et al.  Microporation techniques for enhanced delivery of therapeutic agents. , 2010, Recent patents on drug delivery & formulation.

[43]  H. Katsumi,et al.  Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: evaluation of transdermal absorption, safety, and pharmacological effects after application in rats. , 2012, Journal of pharmaceutical sciences.

[44]  Yohei Mukai,et al.  Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and influenza. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[45]  Karen L Wooley,et al.  Design of polymeric nanoparticles for biomedical delivery applications. , 2012, Chemical Society reviews.

[46]  Priyanka Ghosh,et al.  In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[47]  R H Guy,et al.  Characterization of the iontophoretic permselectivity properties of human and pig skin. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[48]  R. Lockey,et al.  Prevention of airway inflammation with topical cream containing imiquimod and small interfering RNA for natriuretic peptide receptor , 2008, Genetic vaccines and therapy.

[49]  J. Matriano,et al.  Parathyroid Hormone (1-34)-Coated Microneedle Patch System: Clinical Pharmacokinetics and Pharmacodynamics for Treatment of Osteoporosis , 2010, Pharmaceutical Research.

[50]  Marica B. Ericson,et al.  Accumulation of FITC near stratum corneum–visualizing epidermal distribution of a strong sensitizer using two‐photon microscopy , 2009, Contact dermatitis.